Pharmaceutical and biotechnology companies are making substantial research investments in order to develop specific treatments that can destroy both solid and metastasis tumors. Therefore it is the best investment opportunity with social value to the Angel investors, Venture capitalists and health care foundations
ONCOCUR is committed to deliver good value to its shareholders who are key partners in building a sustainable global drug discovery company which constantly endeavors to take nano medicine innovations to the society. Oncocur is a preeminent leader in nano medicine with better efficacy and lower toxicity for cancer therapy. We are a unique bionanotech company with a strong track record for delivering growth based on innovation. We operate a triple bottom line and are thus committed to continuously improving our financial, environmental, and social performance.